Should a prolonged duration of dual anti-platelet therapy be recommended to patients with diabetes mellitus following percutaneous coronary intervention? A systematic review and meta-analysis of 15 studies

BACKGROUND: This study aimed to compare the adverse clinical outcomes associated with a short and a prolonged duration of Dual Anti-Platelet Therapy (DAPT) in patients with Diabetes Mellitus (DM) after undergoing Percutaneous Coronary Intervention (PCI). METHODS: Medline/PubMed, EMBASE and the Cochr...

Descripción completa

Detalles Bibliográficos
Autores principales: Bundhun, Pravesh Kumar, Yanamala, Chandra Mouli, Huang, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5006559/
https://www.ncbi.nlm.nih.gov/pubmed/27577530
http://dx.doi.org/10.1186/s12872-016-0343-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5006559/
https://www.ncbi.nlm.nih.gov/pubmed/27577530
http://dx.doi.org/10.1186/s12872-016-0343-y

Ejemplares similares